Cellular Effects of Wound Fluid (Seroma) from Tumor Bed on Human Breast Cancer Cell Lines Seroma in breast cancer cell lines
Archives of Advances in Biosciences,
Vol. 12 No. 1 (2021),
23 February 2021
,
Page 18-24
https://doi.org/10.22037/aab.v12i1.33564
Abstract
Introduction: Post-lumpectomy wound fluid (seroma) contains many proteins from tumor bed due to physiologic answer to operation and wound healing process. Some cellular tests had been performed on different types of breast cancer (BC) cell lines and normal cell line while treated with seroma.
Materials and Methods: The wound fluid samples were collected from BC patients. The human BC cell lines included MCF-7, MDA-MB-231 as well as normal non-tumorigenic epithelial cell line (MCF-10).
Results: Seroma could inhibit various cancer cells proliferation pattern in comparison with the normal cell. Concerning the cell death, aggressive MDA-MB-231 cells were put into the apoptosis process. Besides, seroma could decrease colony count and size and changed the clone morphology from holoclone to paraclone. Regarding the invasion assay, seroma significantly inhibited cell motility.
Conclusion: By remaining in tumor bed, seroma can induce inhibitory pattern of proliferation, and change the morphology of cancer cell colony and cell motility, consequently leading to positive impact on patients who suffer from cancer.
- Post-lumpectomy wound fluid, apoptosis, colony
How to Cite
References
2. Nold, RJ, Beamer, RL, Helmer, SD, et al. Factors influencing a woman’s choice to undergo breast-conserving surgery versus modified radical mastectomy. The American journal of surgery. 2000; 180(6): 413-8.
3. Massarut S, Belletti B, Segatto I, Piccoli E, Baldassarre G. Wound response after intraoperative radiotherapy. Translational Cancer Research. 2015;4(2):161-72.
4. Miyamoto DT, Harris JR. Molecular predictors of local tumor control in early-stage breast cancer. Semin Radiat Oncol. 2011;21(1):35-42.
5. Yoshida T, Takei H, Kurosumi M, Ninomiya J, Ishikawa Y, Hayashi Y, et al. True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment. Breast J. 2010;16(2):127-33.
6. Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591-6.
7. Wu FP, Hoekman K, Meijer S, Cuesta MA. VEGF and endostatin levels in wound fluid and plasma after breast surgery. Angiogenesis. 2003;6(4):255-7.
8. Hanahan D, Weinberg RA. The hallmarks of cancer. cell. 2000;100(1):57-70.
9. Bahuguna A, Khan I, Bajpai VK, Kang SC. MTT assay to evaluate the cytotoxic potential of a drug. Bangladesh Journal of Pharmacology. 2017;12(2):8-2017.
10. Segatto I, Berton S, Sonego M, Massarut S, Perin T, Piccoli E, et al. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling. Oncotarget. 2014;5(15):6267.
11. Zaleska K, Suchorska WM, Przybyła A, Murawa D. Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines. Oncology letters. 2016;12(5):3707-14.
12. Belletti B, Vaidya JS, D'Andrea S, Entschladen F, Roncadin M, Lovat F, et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clinical Cancer Research. 2008;14(5):1325-32.
13. Valeta-Magara A, Hatami R, Axelrod D, Roses DF, Guth A, Formenti SC, et al. Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions. Springerplus. 2015;4:483.
14. Herskind C, Ma L, Liu Q, Zhang B, Schneider F, Veldwijk MR, et al. Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects. Radiat Oncol. 2017;12(1):24.
15. Zaleska K, Przybyla A, Kulcenty K, Wichtowski M, Mackiewicz A, Suchorska W, et al. Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment. Oncol Lett. 2017;14(4):4029-36.
16. Rieger AM, Nelson KL, Konowalchuk JD, Barreda DR. Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. Journal of visualized experiments: JoVE. 2011(50).
17. Beaver CM, Ahmed A, Masters JR. Clonogenicity: holoclones and meroclones contain stem cells. PLoS One. 2014;9(2):e89834.
18. Liang C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature protocols. 2007;2(2):329.
19. Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV. In vitro cell migration and invasion assays. J Vis Exp. 2014(88).
- Abstract Viewed: 169 times
- PDF Downloaded: 166 times